ERELZI SZ, also known as Etanercept-szzs, is a biosimilar to the original biologic medication Etanercept. It is designed to mimic the effects of the original drug, providing a more cost-effective option for patients. ERELZI SZ is used in the treatment of various autoimmune conditions, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis. It works by inhibiting the action of tumor necrosis factor (TNF), a substance in the body that causes inflammation and is involved in the autoimmune response. By blocking TNF, ERELZI SZ helps to reduce inflammation, alleviate symptoms, and slow the progression of the diseases it is used to treat. Like its reference product, ERELZI SZ is administered through injection.
When using Erelzi (etanercept-szzs), a biosimilar to Enbrel, it's crucial to adhere strictly to your doctor's instructions and thoroughly read the label accompanying the medicine. Erelzi can cause side effects that may impair your ability to drive or operate machinery safely, such as dizziness or fatigue, so it's important to be cautious until you know how the medication affects you. Common side effects include injection site reactions, respiratory infections, and headaches. Although rare, more serious side effects like infections, allergic reactions, or neurological issues can occur. Always inform your doctor about any other medications you're taking to avoid potential interactions. Following your healthcare provider's guidance and promptly reporting any side effects or concerns is essential for your safety while using Erelzi.